VOLITIONRX LTD — Director's Dealing 2019

Feb 13, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2019-02-11

Reporting Person: Micallef Jacob Vincent (Chief Scientific Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-02-11	Stock Option (Right to Buy)	$3.25	A	50000	Acquired	2025-02-11	Common Stock (50000)	Direct

Footnotes

F1: A total of 50,000 Options were granted on February 11, 2019 under the Company's 2015 Stock Incentive Plan. The Options vest in full twelve months from the date of grant.